Suchergebnisse - "Teixeira, Julio"

PubPharm (14)

1

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women

enthalten in: Sexually transmitted diseases | 2019

von El-Zein, M. | Ramanakumar, A. | Naud, P. | +11

2

Evaluation of Type Replacement Following HPV16/18 Vaccination : Pooled Analysis of Two Randomized Trials

enthalten in: Journal of the National Cancer Institute | 2017

von Tota, J. | Struyf, F. | Merikukka, M. | +22

3

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women : results from the control arm of a phase II HPV-16/18 vaccine trial

enthalten in: BMJ open | 2016

von Ramanakumar, A. | Naud, P. | Roteli-Martins, C. | +13

ErratumIn: BMJ Open. 2016 Sep 02;6(9):e011371corr1. - PMID 27591019

4

A Large Multicenter Experience With Endoscopic Suturing for Management of Gastrointestinal Defects and Stent Anchorage in 122 Patients : A Retrospective Review

enthalten in: Journal of clinical gastroenterology | 2016

von Sharaiha, R. | Kumta, N. | DeFilippis, E. | +18

5

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine : combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials

enthalten in: The Lancet. Oncology | 2015

von Kreimer, A. | Struyf, F. | Del Rosario-Raymundo, M. | +142

CommentIn: BMJ. 2015 Jun 11;350:h3198. - PMID 26067838

6

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies : analysis of the control arm of PATRICIA

enthalten in: The Journal of infectious diseases | 2014

von Castellsagué, X. | Naud, P. | Chow, S. | +28

CommentIn: J Infect Dis. 2014 Aug 15;210(4):507-9. - PMID 24610878

7

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine : final analysis of a long-term follow-up study up to 9.4 years post-vaccination

enthalten in: Human vaccines & immunotherapeutics | 2014

von Naud, P. | Roteli-Martins, C. | De Carvalho, N. | +7

8

Natural history of progression of HPV infection to cervical lesion or clearance : analysis of the control arm of the large, randomised PATRICIA study

enthalten in: PloS one | 2013

von Jaisamrarn, U. | Castellsagué, X. | Garland, S. | +127

ErratumIn: PLoS One. 2013;8(12). doi:10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a

9

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial

enthalten in: Gynecologic oncology | 2012

von Roset Bahmanyar, E. | Paavonen, J. | Naud, P. | +124

CommentIn: Gynecol Oncol. 2012 Dec;127(3):437-9. - PMID 23140752

10

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

enthalten in: The Lancet. Oncology | 2012

von Wheeler, C. | Castellsagué, X. | Garland, S. | +125

ErratumIn: Lancet Oncol. 2012 Jan;13(1):e1